Springer Post Covid-19 Neurological Syndrome: A Pathway to SDG-3

This book represents a groundbreaking contribution to the field of neurology, addressing a critical gap in our understanding of the long-term neurological effects of Covid-19. Crafted by frontline researchers, it offers invaluable insights into Post Covid-19 Neurological Syndrome (PCNS), a condition first described by the Editors themselves in 2020. Through a comprehensive synthesis, this volume explores PCNS in the context of the sustainable development goals and the 2030 agenda, providing an up-to-date overview across the spectrum of this syndrome. Comprising both general chapters delving into the pathobiological mechanisms of PCNS, the intricate relationship between Covid-19 infection and brain involvement, as well as a review of current research and barriers to accessing care, this book offers a holistic understanding of the subject matter. Furthermore, it addresses potential therapeutic options and contemporary issues within the framework of the WHO intersectoral global action plan (IGAP) and SDG-3, offering a global perspective on tackling this pressing issue. Neurologists worldwide will benefit greatly from the insights presented in this book, providing them with essential knowledge for diagnosing and treating cases of PCNS, particularly in situations where clinical experience with the condition may be limited. Additionally, international organizations, policymakers, and non-governmental organizations engaged in health and Covid-19 pandemic response efforts will find this resource invaluable. Anticipated to become an indispensable addition to neurological department libraries, this book will serve as a fundamental textbook for teaching neurology. Its profound exploration of the impact of Covid-19 on brain health ensures its relevance for generations to come, solidifying its place as a cornerstone in advancing our understanding and management of neurological sequelae associated with the pandemic.